Long-Term Outcomes With Isatuximab-Carfilzomib-Dexamethasone (Isa-Kd) In Relapsed Multiple Myeloma Patients With 1Q21+ Status: Updated Results From The Phase 3 Ikema Study
Carfilzomib;Dexamethasone;Isatuximab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Long-Term Outcomes With Isatuximab-Carfilzomib-Dexamethasone (Isa-Kd) In Relapsed Multiple Myeloma Patients With 1Q21+ Status: Updated Results From The Phase 3 Ikema Study ### Output: Carfilzomib;Dexamethasone;Isatuximab